Aprogen Biologics Inc. (KRX:003060)
South Korea · Delayed Price · Currency is KRW 1,445.00
-21.00 (-1.43%)
At close: Oct 13, 2026
Aprogen Biologics Market Cap
Aprogen Biologics has a market cap or net worth of 23.39 billion as of October 12, 2026. It is the 37,938th most valuable company in the world and the 2,338th biggest in South Korea. Its market cap has decreased by 80.43% in one year.
Market Cap
23.39B
Enterprise Value
285.00B
Revenue
86.18B
Global Rank
Country Rank
#2,338 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since January 5, 1996, Aprogen Biologics's market cap has increased from 3.18B to 23.39B, an increase of 636.05%. That is a compound annual growth rate of 6.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 23.39B | -77.19% |
| Dec 30, 2025 | 102.54B | -21.60% |
| Dec 30, 2024 | 130.79B | -31.41% |
| Dec 28, 2023 | 190.68B | -4.89% |
| Dec 29, 2022 | 200.48B | -44.42% |
| Dec 30, 2021 | 360.71B | -31.18% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dong Sung Bio Pharm.Co.,Ltd. | 120.45B |
| Jeil Pharma Holdings | 115.90B |
| HANDOK | 111.72B |
| Kukje Pharma | 86.95B |
| CMG Pharmaceutical | 83.25B |
| CKD Bio | 76.86B |
| Enzychem Lifesciences | 76.86B |
| Ildong Holdings | 71.09B |